BioSpace News Archive

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced that Antoni Ribas, M.D., Ph.D. has joined the Company’s Board of Directors.

Welltower Inc. (NYSE: WELL) today announced results for the quarter ended September 30, 2019.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced their participation at The Society for Immunotherapy of Cancer (SITC) occurring November 6th-10th in National Harbor, Maryland.

Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today announced a grant of inducement awards to its Chief Financial Officer, Thomas J. Russo, CFA on October 28, 2019.

EOS® is an innovative 2D / 3D imaging system that results in 2 - 3x less radiation exposure for kids with orthopedic conditions like scoliosis

Seneca Biopharma, Inc., a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, will present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit to be held at the Pudong Shangri-La Hotel in East Shanghai on October 31 – November 1.

Futura Medical plc (AIM: FUM) (the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, today announced that data reported in two abstracts at SMSNA add to the growing body of data supporting the safety and efficacy of the Company’s MED2005 topical gel for the treatment of erectile dysfunction (ED)

On October 16, 2019, Hackensack Meridian Health’s Hackensack University Medical Center performed its first cardiovascular surgery procedures using a new heart pump called the Impella 5.5 with SmartAssist.

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting at the eCOA/ePRO and IRT event in Philadelphia, Pennsylvania from October 28th to 30th, 2019.

Dialyze Direct, a leading kidney care innovation company specializing in advancements in home dialysis, today announced a collaboration with Arbor Research Collaborative for Health (Arbor Research) to conduct a study comparing the dialysis treatments of geriatric patients to younger patients.